Effects of endothelin antagonist on bronchoconstriction elicited by isocapnic hyperpnea in Guinea pigs

梁永杰,蔡映云

DOI: https://doi.org/10.3969/j.issn.0253-9934.2001.10.017

2001-01-01

Abstract:Objective To investigate the effects of endothelin antagonist, Bosentan on bronchoconstriction elicited by isocapnic hyperpnea in guinea pigs and to explore the effect of endothelin in the pathogenesis of exercise induced asthma (E1A). Methods 19 pathogen free Hartley guinea pigs were divided into two groups. A)Bosentan group ( n =10), which was administered by intraperitoneal injection (30 mg/kg) in 24,16 and 8 h respectively before isocapnic hyperpnea challenge. B) Control group ( n =9), water was injected intraperitoneally(lml/kg) 24,16,and 8 h prior to the challenge. A rodent respirator with dry 5% CO 2, 95% O 2 mixture at room emperature provided mechanical ventilation (VT 8 ml/animal, 100 breaths/min) for 5 min. The lung resistance (RL) and the dynamic compliance (Cdyn) of the two groups were measured before and after isocapnic hyperpnea challenge. The percentages of BALF collected in both groups were assessed. Results In the control group, isocapnic hyperpnea of dry gas elicited a marked increase in RL and decrease in Cdyn. RL and Cdyn of the guinea pigs from Bosentan group did not change significantly.The percentage of BALF collected in Bosentan group was more than that in the control group. Conclusion It was demonstrated that ET receptor antagonist Bosentan inhibited the bronchoconstriction induced by isocapnic hyperpnea in guinea pigs. It is suggested that ET receptor antagonist might be beneficial in prevention and treatment of exercise induced asthma. The present investigative profile makes Bosentan a potentially useful drug in the management of clinical disorders associated with bronchoconstriction.